Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
CORTICUS: Hydrocortisone for Septic Shock
NCT00147004Phase 3Completed
- Sponsor
- Hadassah Medical Organization
- Start
- Mar 2002
- Primary completion
- Nov 2005
- Modality
- Small Molecules
- Countries
- 9
01
Overview
A Phase 3 trial of hydrocortisone in septic shock, sponsored by Hadassah Medical Organization. Started Mar 2002; status: completed.
02
Drugs
hydrocortisone
03
Conditions
septic shock
Beyond the preview
Go deeper on NCT00147004.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00147004.